Executive summary
A diagnostic that establishes the country evidence baseline for an international expansion sequencing decision and exposes the gaps and comparability problems before any sequence is proposed.
What is inside
What the diagnostic covers
The asset takes the sequencing question and the candidate country list and walks the team through screening every candidate on a fixed evidence pack, harvesting internal entry cost and ramp history from existing markets, building a full scored inventory for the shortlisted countries, testing whether the numbers are comparable across countries, registering gaps with owners and dates, and taking the baseline through a sign-off gate.
- Scope: the sequencing question, the candidate country list and the evidence baseline
- A two-tier evidence structure: a screening view of every candidate and a deeper view of the shortlist
- Country evidence across demand, localization and regulation, distribution economics and internal track record
- Quality and currency checks on every source, with explicit thresholds
- A comparability test that shows where country numbers cannot be ranked against each other
- A gap register with owners and closure dates
- A baseline sign-off gate before sequencing options are appraised